NDC 51525-0115-01 - Hyoscyamine ER

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51525-0115
Requested NDC
51525-0115-01
Package NDCs from labels
51525-0115-1, 51525-0115-01
Manufacturer
Mylan Pharmaceuticals Inc.
Effective date
2023-07-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx onlyMylan Pharmaceuticals Inc.2023-07-15HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51525-0115-1HyoscyamineER100 in 1 BOTTLETABLET, EXTENDED RELEASE1004

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51525-0115HYOSCYAMINE ER (HYOSCYAMINE SULFATE) TABLET, EXTENDED RELEASE [WALLACE PHARMACEUTICALS INC.]3Current NDC, Legacy NDC, 1 package rows20181219_5bbce8c0-a9c9-45b9-8457-1542bd3d9449.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51525-0115-1EA - Each51525-011585cd83a7-0a00-424b-8c00-f285e52ec8aa12016-07-19

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 4 · 68 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hyoscyamine SulfateHYOSCYAMINE SULFATEBryant Ranch Prepack57b26b7f-f22d-4ffb-a748-d430572f92a72023-04-12Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine HydrobromidePHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDEIngenus Pharmaceuticals, LLC33bf2df5-bc53-4d57-a9e7-41f3fc0a03f02023-01-12Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine HydrobromidePHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE AND SCOPOLAMINE HYDROBROMIDEIngenus Pharmaceuticals, LLC0dd71f55-e009-48dd-809d-5f651f7521de2023-01-10Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
DonnatalPHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDEVistaPharm, LLC11a48ba9-576b-4e8c-9536-6e83636d69302022-07-07Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
PhenohytroPHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDEWinder Laboratories, LLC27c8baac-f8ce-46d8-8a0f-ff769dd408d92019-12-27Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
PhenohytroPHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDEWinder Laboratories LLC29be31ef-108e-4b45-9ecc-b6d671da28262019-10-04Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
URELLEHYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEViatris Specialty LLC1d80a11c-6f86-403b-85d4-32ec1924dbe92015-01-13Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Levsin SLHYOSCYAMINE SULFATEViatris Specialty LLCf38ece41-b890-11e2-9e96-0800200c9a662013-05-14Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.